Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05EMW
|
|||
| Former ID |
DIB008029
|
|||
| Drug Name |
Long-acting polysialic acid-interferon alpha 2b conjugate
|
|||
| Synonyms |
InferoXen; Long-acting polysialic acid-interferon alpha 2bconjugate (PolyXen, HCV infection); Long-acting polysialic acid-interferon alpha 2b conjugate (PolyXen, HCV infection), Lipoxen/SynBio
Click to Show/Hide
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Investigative | [1] | |
| Company |
Lipoxen plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.